What else should you know about B12 Injections
Lower appetite and GI side effects can make people eat and drink less
In 2024, Independence Health Group, the for-profit parent company of the nonprofit Philadelphia-based health insurance company Independence Blue Cross, reported a net loss of $239 million, despite generating $32 billion of revenue, citing a sharp increase in medical and pharmacy costs. One driver behind these losses is the rapid growth of weight-loss medications, including glucagon-like peptide-1 receptor agonists, known as GLP-1s, such as Ozempic
When to contact your healthcare provider: If you have used medication that you later discovered was expired, improperly stored, or visually abnormal, contact your provider
Medical availability disclaimer: Information about a peptide on this page does not guarantee that it is currently available, appropriate or legally dispensable in your location
For an approved GLP-1 example, Semaglutide Weight Loss Medication covers expectations and safety questions in a separate setting